Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

(NasdaqGM:TRDA), BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that Dipal Doshi, Chief Executive Officer, will deliver a company presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 3:45 PM PT (6:45 PM ET). A live webcast will be available on the Presentations […]

Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers

(LSE – AIM:AVCT), Preliminary Phase 1b data is in line with Phase 1a data reported at the European Society of Medical Oncology in September 2025 Combined disease control rate of 90% across both Phase 1a and Phase 1b patients with confirmed partial and minor responses observed LONDON and PHILADELPHIA, Dec. 17, 2025 (GLOBE NEWSWIRE) —

CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system

16 December 2025 CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system Regulatory clearance of CMR's most advanced system paves the way for upcoming US commercial launch Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global medical technology company, today announces its second-generation surgical robotic platform,

Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC

Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC The study is designed to evaluate the safety and clinical activity of NXP900 in combination with osimertinib in patients with epidermal growth factor receptor mutated (EGFR mut+) non-small cell lung cancer (NSCLC) whose cancers initially

New Book Helps Close the Leadership Gap in Crisis Readiness

New Book Helps Close the Leadership Gap in Crisis Readiness GlobeNewswire December 17, 2025 BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) — A new book by veteran crisis communications expert Tara Goodwin, founder of Goodwin Consulting, addresses a persistent and costly leadership failure: most organizations remain unprepared to lead effectively when crisis strikes. Most companies fail

Xali Gold to Close First Tranche of Private Placement December 19, 2025

Xali Gold to Close First Tranche of Private Placement December 19, 2025 GlobeNewswire December 17, 2025 Not for dissemination in the United States or for distribution to U.S. Newswire Services VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) — Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) is pleased to announce that it plans

Bitcoin Munari Confirms Final Presale at $0.015 With No Further Rounds Planned

Bitcoin Munari Confirms Final Presale at $0.015 With No Further Rounds Planned GlobeNewswire December 17, 2025 HELSINKI, Finland, Dec. 17, 2025 (GLOBE NEWSWIRE) — Bitcoin Munari has confirmed that it will conduct a single, final presale round priced at $0.015 per token, scheduled to run from December 17 through December 23. The announcement formally closes

Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for 90 Days

Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for 90 Days GlobeNewswire December 17, 2025 CALGARY, Alberta, Dec. 17, 2025 (GLOBE NEWSWIRE) — TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) confirms that its subsidiary, TransAlta Centralia Generation LLC, has received an order (the Order) from the United States Department

When Holiday Cheer Turns to Holiday Stress: A Look at the Mind Behind Seasonal Emotions

When Holiday Cheer Turns to Holiday Stress: A Look at the Mind Behind Seasonal Emotions GlobeNewswire December 17, 2025 LOS ANGELES, Dec. 17, 2025 (GLOBE NEWSWIRE) — As the holiday season reaches its most demanding time, expectations of joy, celebration and seasonal “magic” collide with a very different emotional reality–one marked by stress, sadness and

Mutuum Finance (MUTM) Advances Through Roadmap Phase 2 with Phase 6 99% Allocated and over $19.4M Raised

Mutuum Finance (MUTM) Advances Through Roadmap Phase 2 with Phase 6 99% Allocated and over $19.4M Raised GlobeNewswire December 17, 2025 DUBAI, United Arab Emirates, Dec. 17, 2025 (GLOBE NEWSWIRE) — As the top crypto market continues to filter out short-term narratives, attention is increasingly drawn to projects that are quietly reaching important internal milestones.

Scroll to Top